Fig. 1

Effect of steroid treatment on metabolic and liver parameters. Three groups of C57BL/6 mice were followed for eight weeks to assess the preventive effect of GC on the development of steroid-mediated liver damage. Group A received vehicle alone; Group B received Dexamethasone, and group C received a combination of Dexamethasone with GC. Mice were followed for fasting serum glucose levels (a); postprandial glucose levels as manifested by glucose tolerance test absolute values (b) and AUC (c); serum insulin levels (d); serum triglyceride levels (e); and AST and ALT liver enzymes (f) (**p < 0.01, *p < 0.05).